T-Rex 2X Long MSTR Daily Target ETF vs Teladoc Health Inc — how do they compare? T-Rex 2X Long MSTR Daily Target ETF trades at $39.87 (market cap $809.00M), while Teladoc Health Inc trades at $5.79 (market cap $1.01B). The key difference: Teladoc Health Inc is the larger of the two by market cap, and Teladoc Health Inc is trading nearer its 52-week high, T-Rex 2X Long MSTR Daily Target ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold T-Rex 2X Long MSTR Daily Target ETF for 18 Days and Teladoc Health Inc for 39 Days on average.
| MSTU | TDOC | |
|---|---|---|
Market Cap | $809.00M | $1.01B |
Volume | 4,577,465 | 4,668,477 |
Sector | Leveraged / Inverse | Health |
52-Week High | $451.00 | $9.72 |
52-Week Low | $14.60 | $4.47 |
Typical Hold Time | 18 Days | 39 Days |
Enterprise Value | — | $1.27B |
Signals from Pluang's Aura AI — not financial advice
MSTU trades at $39.70, up 0.63% with bearish technical indicators showing 8 buy vs 13 sell signals. The stock faces resistance at $40-$43 with support at $37-$33. Recent corporate actions include a 10:1 reverse stock split effective August 24, 2026, and a $0.29 dividend declaration for H2-2026. Trading activity remains elevated as investors seek leveraged exposure to the underlying company.
The outlook remains cautious with technical weakness outweighing neutral oscillators. Key risks include the leveraged ETF structure's daily rebalancing effects and dependence on underlying stock volatility. Investment appeal hinges on continued institutional interest in the strategy exposure, though the bearish technical setup suggests near-term pressure.
Teladoc Health (TDOC) trades at $5.77, up 3.78% today but remains near multi-year lows amid ongoing profitability challenges. The stock shows bearish technical signals with mixed earnings performance, having beaten estimates in two of the last three quarters but posting consistent net losses. Recent management changes include the appointment of a new CFO and legal officer as the company focuses on stabilizing its integrated care business while grappling with BetterHelp segment weakness.
While TDOC trades at discounted valuation multiples (P/S 0.4x, P/B 0.77x) and analysts maintain a $8.83 price target, the path to profitability remains uncertain given seven consecutive quarters of negative earnings. The primary investment thesis hinges on the company's ability to monetize its chronic care platform and achieve sustainable free cash flow generation, though investor sentiment remains cautious amid ongoing losses and competitive pressures in virtual healthcare.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
MSTU is a leveraged ETF that seeks daily investment results corresponding to 200% of the daily performance of the MicroStrategy Incorporated (MSTR) stock. It is designed as a tactical tool for experienced traders to take a bullish (long) position in MSTR, a company known for its significant Bitcoin holdings. Due to the effects of compounding and leverage, the ETF is intended to be held for a single day and is not suitable for long-term investment.
Read more on MSTU →Teladoc Health is a virtual health provider with a telehealth platform delivering 24-hour, on-demand healthcare via mobile devices, the internet, video, and phone. It also offers remote patient monitoring programs for chronic care management. Its platform connects members with a network of physicians and behavioral health professionals. Most of the company's revenue is generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems. Since inception, Teladoc has primarily partnered with employers, health plans, and health systems to offer network access to their members.
Read more on TDOC →